早期临床改善与拉莫特里金增强在重症治疗耐药单极性抑郁症:一个案例报告
Nikith Senthilkumar1, Rachel Daly1
1Psychiatry, Little Brooke Hospital, Dartford, GBR.
Cureus
|December 22, 2025
概括
当标准抗抑郁药失败时,拉莫素增强可能会快速改善严重的耐治疗抑郁症 (TRD). 这项案例研究显示,在三周内,情绪和自我护理显著改善,突出了lamotrigine.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐治疗抑郁症 (TRD) 是一个重大的临床挑战,其增强选择有限.
- 对于严重的TRD病例来说,常规抗抑郁药通常是不够的.
- 在双极性抑郁症中批准使用的抗抗药拉莫,在单极性TRD中显示出不一致的结果,并非标签上使用.
研究的目的:
- 报告一个严重的TRD病例成功治疗了lamotrigine增强.
- 为了突出TRD中拉莫特里金的快速反应的潜力.
- 强调需要对拉莫特里金的疗效和TRD中反应预测因子进行进一步研究.
主要方法:
- 这里介绍了一个45岁的男性患者的病例报告,他患有严重的TRD.
- 这位患者曾经在多次抗抑郁药试验中失败.
- 由于缺乏对以前治疗的反应,因此启动了lamotrigine增强.
主要成果:
- 患者在3周内体验到情绪,参与度和自我照顾的显著改善.
- 自杀想法显著减少.
- 通过PHQ-9测量抑郁症的严重程度从23 (严重) 降至3 (最小).
结论:
- 拉莫特里金增强可以是一个有价值的选择,患者严重的TRD谁不响应常规治疗.
- 观察到的快速反应表明了潜在的疗效,需要进一步研究.
- 鉴定TRD中拉莫特里金早期反应的预测因子对于临床应用至关重要.
相关概念视频
01:24Mania and Antimanic Drugs: Overview
526
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
526
01:30Electroconvulsive Therapy
780
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
780
01:23Antidepressant Drugs: MAOIs and Other Agents
765
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
765
01:26Psychosis: Goals of Pharmacotherapy
436
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
436
01:28Drug Therapy
229
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
229
01:03Long-term Depression
3.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.0K